IsoniazidAntitubercular AgentsRifampinMycobacterium tuberculosisPyrazinamideEthambutolAntibiotics, AntitubercularTuberculosis, Multidrug-ResistantTuberculosisTuberculosis, PulmonaryTreatment OutcomeEthionamidePsychotropic DrugsAntidepressive AgentsPsychopharmacologyAntipsychotic AgentsRespiratory System AgentsMethylphenidateDrug Therapy, CombinationStreptomycinAminosalicylic AcidsSertralineAminosalicylic AcidUrological AgentsMicrobial Sensitivity TestsPropylaminesSerotonin Uptake InhibitorsDrug Resistance, BacterialDrug TherapyCholinesterase InhibitorsAprindineIsonicotinic AcidsCentral Nervous System StimulantsTime FactorsPseudoephedrineCatalaseAnti-Anxiety AgentsCognitive TherapyCardiovascular AgentsCyclobutanesMemantineClinical Trials as TopicAlcohol-Induced Disorders, Nervous SystemDyskinesiasRandomized Controlled Trials as TopicThioacetazoneDextroamphetamineMycolic AcidsPractice Guidelines as TopicDisease Models, AnimalCyclohexanecarboxylic AcidsMycobacteriumAnticonvulsantsDrug Resistance, Multiple, BacterialAntidepressive Agents, TricyclicAntimanic AgentsNootropic AgentsLatent TuberculosisSchizophreniaAppetite DepressantsBipolar DisorderPsychotherapyRisperidoneParoxetineDrug Resistance, MicrobialMycobacteriophagesAttention Deficit Disorder with HyperactivityAdrenergic beta-AntagonistsBacterial ProteinsEvidence-Based MedicineMedication AdherenceMutationAnti-Arrhythmia AgentsNarcotic AntagonistsAza CompoundsBenzodiazepinesSputumPainTuberculin TestAntihypertensive AgentsRisk FactorsDepressive DisorderPsychiatric Status Rating ScalesMycobacterium smegmatisClofazimineArylamine N-AcetyltransferasePulmonary Disease, Chronic ObstructiveRifamycinsHydrazinesAnalysis of VarianceAnxiety DisordersOxidoreductasesPatient ComplianceBrainCombined Modality TherapyChronic DiseaseBronchodilator AgentsColony Count, MicrobialDose-Response Relationship, DrugAdrenal Cortex Hormones